logo
Loading...
Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
Medicine and HealthNature Communications

Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine

N. Islam, N. E. Sheils, et al.

This study, conducted by Nazmul Islam, Natalie E. Sheils, Megan S. Jarvis, and Kenneth Cohen, reveals that the mRNA-1273 (Moderna) vaccine offers slightly more protection against SARS-CoV-2 infection compared to the BNT162b2 (Pfizer-BioNTech) vaccine, particularly at 90 days post-vaccination, although both vaccines show similar protection against severe outcomes. Dive into the findings of over 3.5 million fully vaccinated individuals!... show more
Introduction
Literature Review
Methodology
Key Findings
Discussion
Conclusion
Limitations
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny
    Comparative effectiveness over time of the mRNA-1273 | ResearchBunny